Research never stops

Top Story

Evotec AG: 'LAB282' awarded first projects

Hamburg, Germany, 21 February 2017:
Evotec AG is pleased to announce that LAB282, the £ 13 m (over EUR 15 m) drug discovery partnership with Oxford University, has made its first wave of awards, backing projects targeting cardiovascular diseases and infectious diseases.

- read more

Novo A/S becomes new long-term strategic shareholder in Evotec

Hamburg, Germany, 09 February 2017:
Evotec AG today announced that it resolved on a capital increase from its authorised capital against cash.

- read more

Cyprotex, an Evotec company, expands into new UK facility at Alderley Park

Hamburg, Germany - 26 January 2017: Evotec AG today announced that Cyprotex, a company wholly owned by Evotec AG, has completed the relocation of its UK operations from Macclesfield to Alderley Park.

- read more
loading weather report
Loading weather report...


Feb 28, 2017 - Life science conference

Mar 15, 2017 - BioCapital Europe

Company Presentation February

Building integrated and high-value drug discovery alliances
2017-02_Evotec_Company presentation_February